BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nunes ACR, Amaro P, Maçôas F, Cipriano A, Martins I, Rosa A, Pimenta I, Donato A, Freitas D. Fosinopril-induced prolonged cholestatic jaundice and pruritus: first case report: . European Journal of Gastroenterology & Hepatology 2001;13:279-82. [DOI: 10.1097/00042737-200103000-00011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Palta R, Thobani S, Donovan JA, Kanel GC, Gutierrez G, Fong T. Prolonged Cholestasis Associated With Benazepril Therapy. Am J Gastroenterol 2009;104:245-6. [DOI: 10.1038/ajg.2008.42] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Green BR, Bain LJ. Mrp2 is involved in the efflux and disposition of fosinopril: Mrp2 is involved in the efflux and disposition of fosinopril. J Appl Toxicol 2013;33:458-65. [DOI: 10.1002/jat.1767] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
3 Zalawadiya SK, Sethi S, Loe S, Kumar S, Tchokonte R, Shi D, Adam AK, May EJ. Unique case of presumed lisinopril-induced hepatotoxicity. American Journal of Health-System Pharmacy 2010;67:1354-6. [DOI: 10.2146/ajhp100083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Bonkovsky HL, Jones DP, Labrecque DR, Shedlofsky SI. Drug-Induced Liver Injury. Zakim and Boyer's Hepatology. Elsevier; 2006. pp. 503-50. [DOI: 10.1016/b978-1-4160-3258-8.50031-0] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
5 Douros A, Kauffmann W, Bronder E, Klimpel A, Garbe E, Kreutz R. Ramipril-Induced Liver Injury: Case Report and Review of the Literature. American Journal of Hypertension 2013;26:1070-5. [DOI: 10.1093/ajh/hpt090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mohi-ud-din R, Lewis JH. Drug- and chemical-induced cholestasis. Clin Liver Dis. 2004;8:95-132, vii. [PMID: 15062196 DOI: 10.1016/s1089-3261(03)00124-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 10] [Article Influence: 3.1] [Reference Citation Analysis]
7 Wong F. Renal diseases and the liver. Clin Liver Dis 2011;15:39-53. [PMID: 21111992 DOI: 10.1016/j.cld.2010.09.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
8 Brewer C, Wong VS. Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature. Addiction Biology 2004;9:81-7. [DOI: 10.1080/13556210410001674130] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
9 Halegoua-de Marzio D, Navarro VJ. Hepatotoxicity of Cardiovascular and Antidiabetic Drugs. Drug-Induced Liver Disease. Elsevier; 2013. pp. 519-40. [DOI: 10.1016/b978-0-12-387817-5.00029-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
10 Albert JG, Fiedler E, Marsch WC, Helmbold P. Consequences of Detecting Small Bowel Metastasis of Malignant Melanoma by Capsule Endoscopy. Am J Gastroenterol 2008;103:244-5. [DOI: 10.1111/j.1572-0241.2007.01562_6.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Velayudham LS, Farrell GC. Drug-induced cholestasis. Expert Opin Drug Saf. 2003;2:287-304. [PMID: 12904107 DOI: 10.1517/14740338.2.3.287] [Cited by in Crossref: 60] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
12 Gokcimen A, Kocak A, Kilbas S, Bayram D, Kilbas A, Cim A, Kockar C, Kutluhan S. Effect of lisinopril on rat liver tissues in L-NAME induced hypertension model. Mol Cell Biochem 2007;296:159-64. [DOI: 10.1007/s11010-006-9310-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
13 Chou J, Yu C, Chuang P, Lai H, Hsu C, Cheng K, Peng C, Chiang I. Successful Treatment of Fosinopril-Induced Severe Cholestatic Jaundice with Plasma Exchange. Ann Pharmacother 2008;42:1887-92. [DOI: 10.1345/aph.1l229] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
14 Levy C, Lindor KD. Drug-induced cholestasis. Clinics in Liver Disease 2003;7:311-30. [DOI: 10.1016/s1089-3261(03)00032-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
15 Trauner M, Boyer JL. Cholestatic syndromes: . Current Opinion in Gastroenterology 2002;18:314-29. [DOI: 10.1097/00001574-200205000-00005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
16 Coleman CI, Spencer JV, Chung JO, Reddy P. Possible gatifloxacin-induced fulminant hepatic failure. Ann Pharmacother 2002;36:1162-7. [PMID: 12086547 DOI: 10.1345/aph.1A414] [Cited by in Crossref: 30] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]